The British journal of psychiatry : the journal of mental science

The British journal of psychiatry : the journal of mental science
Audio Summaries

Every issue of The British journal of psychiatry : the journal of mental science moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

119 audio summariesNLM Catalog

Specialties

The British journal of psychiatry : the journal of mental science covers research in these specialties.

Recent summaries

The latest articles summarized from The British journal of psychiatry : the journal of mental science.

Global burden of depressive disorders attributable to childhood sexual abuse and bullying victimisation in adolescents and young adults from 1990 to 2021, with years lived with disability projections to 2050: Global Burden of Disease study analysis.

Nov 9, 2026

This Global Burden of Disease 2021 analysis quantified how much depressive disorder among adolescents and young adults is attributable to childhood sexual abuse (CSA) and bullying victimisation, and how this burden changed from 1990 to 2021. Bullying victimisation accounted for the larger share (73.31%) of the burden in 2021, versus 11.81% for CSA, and both rose over the period, with bullying rising faster. Bayesian projections suggest CSA-related burden will keep increasing to 2050 while bullying-related burden may decline, though the authors caution that future prevention efforts and reporting patterns add uncertainty.

Intimate partner violence and its association with mental disorders among women in the general population, pregnant women and postpartum women: systematic review and meta-analysis.

Nov 9, 2026

This systematic review and meta-analysis asked whether intimate partner violence (IPV) is associated with specific mental disorders among women in the general population, pregnant women, and postpartum women. Pooling 82 cross-sectional, case-control, and cohort studies (140,286 participants), the authors found that IPV was associated with higher odds of depression and anxiety across these groups, with odds ratios ranging from about 2 to 3.6. The findings support the need to address the root causes of IPV and to expand access to mental health services for affected women.

Should distress and impairment be required for psychiatric diagnosis?

Nov 9, 2026

This paper asks whether distress and impairment should be required criteria for an individual psychiatric diagnosis, as DSM-style criteria often demand. The authors argue they should not be universal requirements, proposing that four distinct questions be separated: why a condition belongs in psychiatric classification, whether a person meets its criteria, how significant the condition is for that individual, and what response is warranted.

Psychological and psychosocial interventions for the treatment of antenatal maternal depression: systematic review and network meta-analysis.

Nov 9, 2026

This network meta-analysis asked which non-pharmacological interventions best treat clinically diagnosed antenatal depression, a question that matters because medication during pregnancy is often avoided. Across ten randomised trials (1,853 participants), cognitive-behavioural therapy showed the largest reduction in depressive symptoms compared with treatment-as-usual (SMD -0.83), with other interventions showing smaller, less certain effects. Although CBT appears both effective and acceptable, the authors note that certainty of evidence was very low, so the findings support current guidelines but call for more high-quality trials.

Data donation as an engine for passive sensing research in psychiatry.

Nov 6, 2026

This commentary asks whether patient-driven data donation, which draws on widespread health self-tracking, can address the small effect sizes and reliability problems that limit passive sensing research in psychiatry. The authors argue that donated data could enable larger, more diverse datasets than typical underpowered, unrepresentative studies, thereby improving the validity of inferences drawn from passive measures.

Learning from deaths to improve lives: why England still needs a national LeDeR programme.

Nov 3, 2026

This commentary argues that England should retain the national LeDeR (Learning from Lives and Deaths of People with a Learning Disability and Autistic People) programme, described as the world's only national mortality review system for people with intellectual disability. The authors' central question is whether abandoning national mortality surveillance would make preventable deaths less visible and worsen healthcare inequity for these populations.

Time for psychiatry to seriously consider broad-spectrum micronutrients.

Oct 28, 2026

This commentary argues that broad-spectrum micronutrient (BSM) supplements deserve serious consideration in psychiatry, asking whether they should be an informed treatment option for psychological distress. The authors point to randomised controlled trials showing benefits for emotional regulation, irritability, and aggression, with effect sizes they describe as modest but comparable to cognitive-behavioural therapy and antidepressants.

It takes a village to raise a child: how evolutionary anthropology can inform perinatal psychiatry.

Oct 26, 2026

This paper asks whether perinatal depression and anxiety may partly stem from an evolutionary mismatch: humans evolved to raise children collectively, while modern mothers often parent in isolation. The authors argue this mismatch could complement the established biopsychosocial causes of perinatal disorders and outline its implications for clinical care, health services, and policy.

Metabolic biomarker levels before and after initiation of GLP-1 receptor agonist treatment among individuals with schizophrenia: interrupted time-series analysis.

Oct 24, 2026

This Danish nationwide registry study examined whether starting a GLP-1 receptor agonist was followed by improvements in metabolic markers among 3,042 individuals with schizophrenia, using interrupted time-series analysis. Among those starting treatment for diabetes, HbA1c, LDL, and triglyceride levels dropped by 11.4%, 6.2%, and 14.8%, respectively, while those starting for overweight saw reductions of 3.4%, 4.9%, and 12.7%. The findings suggest that the metabolic benefits seen in randomised trials of GLP-1 receptor agonists in schizophrenia also extend to routine clinical practice, though the observational design cannot fully rule out other explanations.

Clinical and genetic correlates of a circadian subtype of depression in the Australian Genetics of Depression Study.

Oct 20, 2026

This cross-sectional study of 2,604 Australian adults (23% of the sample) tested whether a circadian subtype of depression, defined by meeting at least three of six circadian-related features, reflects a biologically and clinically meaningful group. Compared with the non-circadian subtype, the circadian group had earlier onset, more severe symptoms, poorer self-reported response to SSRIs and SNRIs, and higher polygenic risk scores for psychiatric, metabolic, inflammatory, and sleep/circadian traits. The authors conclude that the circadian subtype has face validity and possible clinical utility, though independent replication and further biological and predictive work are needed.

Listen to The British journal of psychiatry : the journal of mental science

14-day free trial. Every new article, summarized in ~3 minutes.